Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 336 and SP

The 336 seems to be the predominate issue with most investors. Since there doesn't seem to be any other significant news on the horizon if I were responsible for our ASHM this year I think I would enlightened the shareholders with the recent new developements with the 336 and our ongoing challenges at the USPTO. And that is why I believe Chicago was picked for our meeting because our Lawyer, Mr. Henneman, has his offices there.

Share
New Message
Please login to post a reply